Immune responses of prematurely born infants to Hepatitis B vaccination: Results through three years of age

Pediatric Infectious Disease Journal

Volumn 17, Issue 2, 1998, Pages 116-119

  Kesler, Kenneth ^a,b   Nasenbeny, Jerry ^a   Wainwright, Robert ^a   Mcmahon, Brian ^a   Bulkow, Lisa ^a  

^a Providence Alaska Medical Center   (United States)

^b NONE   (United States)

Author keywords

Hepatitis B vaccine; Immunogenicity; Preterm infants

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; PREMATURITY; PRIORITY JOURNAL; UNITED STATES; VACCINATION;

CHILD, PRESCHOOL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INUITS; MALE; VACCINATION;

EID: 0031906599     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199802000-00007     Document Type: Article

References (21)

1. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. JAMA 1990;263:1218-22.
2. Lee P, Lee C, Huang L, Chang M. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr 1995;126:716-21.
3. Stevens CE, Toy PT, Taylor PE, Lee T, Yip H. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long term protection. Pediatrics 1992; 90:170-3.
4. Poovorawan Y, Sanpavat S, Pongpunglert W, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B antigen positive mothers. Pediatr Infect Dis J 1992;11:816-21.
5. Lau Y, Tam AYC, Ng KW, et al. Response of preterm infants to hepatitis B vaccine. J Pediatr 1992;121:962-5.
6. Chawareewong S, Jirapongsa A, Lokaphadhana K. Immune response to hepatitis B vaccine in premature neonates. Sourtheast Asian J Trop Med Public Health 1991;22:39-40.
7. AbuLaimoun BM, Gelardi N, Cashore WJ, Oh W, Peter G. Immune response of preterm infants to hepatitis B vaccine [Abstract 595]. Pediatr Res 1996;39:102A.
8. Losonsky GA, Stephens I, Mahoney F, et al. Preliminary results evaluating the immunogenicity of hepatitis B vaccination of premature infants starting in the first week of life. [Abstract 1752]. Pediatr Res 1995;37:295A.
9. Patel DM, Butler JM, Feldman S, et al. Hepatitis B vaccine in very low birthweight infants [Abstract 1767]. Pediatr Res 1995;37:297A.
10. Hall CB, Easton JG, Granoff DS, et al. (Committee on Infectious Diseases, 1991 to 1992). Universal hepatitis B immunization. Pediatrics 1992;89:795-800.
11. Chirico G, Belloni C, Gasparoni A, et al. Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers. Pediatrics 1993;92:717-9.
12. Lieming D, Mintai Z, Yinju W, Shaochon Z, Weiqin K, Smego RA. A 9-year follow up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high risk Chinese neonates. Clin Infect Dis 1993;17:475-9.
13. Coursaget P, Yvonnet B, Gilks W, et al. Scheduling of revaccination against hepatitis B virus. Lancet 1991;337: 1180-3.
14. Jilg W, Schmidt M, Delnhardt F. Decline of anti-HBs after hepatitis vaccination and timing of revaccination. Lancet 1990;2:173-4.
15. Cousaget P, Yvonnet B, Chotart J, et al. Seven year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986;2:1143-5.
16. Hadler S. Are booster doses of hepatitis B vaccine necessary? Ann Intern Med 1988;108:458-9.
17. Wainwright RB, McMahon BJ, Bulkow LR, Parkinson AJ, Harpster AP. Protection provided by hepatitis B vaccine in a Yupic Eskimo population. Arch Intern Med 1991;151: 1634-6.
18. Lo KJ, Lee SD, Tsai YT, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg positive HBsAg carrier mothers. Hepatology 1988;8:1647-50.
19. Xu Z, Duan S, Margolis HS, et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. J Infect Dis 1995;171:54-60.
20. Keyserling H, West D, Hesley T, Bosley C, Wiens B, Calandra G. Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four, and twelve or fifteen months of age. J Pediatr 1994;125:67-9.
21. Greenberg D. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J 1993;12:438-45.